Home Other Building Blocks 1010836-56-2
1010836-56-2,MFCD19103514
Catalog No.:AA008U58

1010836-56-2 | 4-(Hydroxymethyl)tetrahydro-2h-pyran-4-carbonitrile

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$30.00   $21.00
- +
250mg
95%
in stock  
$49.00   $34.00
- +
500mg
95%
in stock  
$95.00   $67.00
- +
1g
95%
in stock  
$159.00   $111.00
- +
2g
95%
in stock  
$315.00   $220.00
- +
5g
95%
in stock  
$558.00   $391.00
- +
10g
95%
in stock  
$926.00   $648.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA008U58
Chemical Name:
4-(Hydroxymethyl)tetrahydro-2h-pyran-4-carbonitrile
CAS Number:
1010836-56-2
Molecular Formula:
C7H11NO2
Molecular Weight:
141.1677
MDL Number:
MFCD19103514
SMILES:
OCC1(CCOCC1)C#N
Properties
Computed Properties
 
Complexity:
152  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
-0.6  

Downstream Synthesis Route

[1]CurrentPatentAssignee:KyowaKirin(in:KirinHoldings);KIRINHOLDINGSCO.,LTD.-EP2090570,2009,A1Locationinpatent:Page/Pagecolumn96

[2]Wang,Beilei;Wu,Jiaxin;Wu,Yun;Chen,Cheng;Zou,Fengming;Wang,Aoli;Wu,Hong;Hu,Zhenquan;Jiang,Zongru;Liu,Qingwang;Wang,Wei;Zhang,Yicong;Liu,Feiyang;Zhao,Ming;Hu,Jie;Huang,Tao;Ge,Juan;Wang,Li;Ren,Tao;Wang,Yuxin;Liu,Jing;Liu,Qingsong[EuropeanJournalofMedicinalChemistry,2018,vol.158,p.896-916]

[3]CurrentPatentAssignee:GENFLEETTHERAPEUTICSSHANGHAI;SHANGHAIJIONGSHUOPHARMACEUTICALTECHNOLOGY-EP3613737,2020,A1Locationinpatent:Paragraph0062

[4]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66065,2012,A1Locationinpatent:Page/Pagecolumn82-83

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/66070,2012,A1Locationinpatent:Page/Pagecolumn90

[6]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2012/101066,2012,A1Locationinpatent:Page/Pagecolumn96-97

[7]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2012/101065,2012,A2Locationinpatent:Page/Pagecolumn86

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US2012/225062,2012,A1Locationinpatent:Page/Pagecolumn76

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US2012/225062,2012,A1

944804-88-0    1010836-56-2   
tert-butyl(4-bromothiazol-2-yl)((4-cyanotetrahydro-2H-pyran-4-yl)methyl)carbamate 

[1]EuropeanJournalofMedicinalChemistry,2018,vol.158,p.896-916

[2]Patent:EP3613737,2020,A1.Locationinpatent:Paragraph0063

1010836-56-2   
4-(((4-(5-chloro-2-(((1R,4r)-4-(((R)-1-methoxypropan-2-yl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile 

[1]Wang,Beilei;Wu,Jiaxin;Wu,Yun;Chen,Cheng;Zou,Fengming;Wang,Aoli;Wu,Hong;Hu,Zhenquan;Jiang,Zongru;Liu,Qingwang;Wang,Wei;Zhang,Yicong;Liu,Feiyang;Zhao,Ming;Hu,Jie;Huang,Tao;Ge,Juan;Wang,Li;Ren,Tao;Wang,Yuxin;Liu,Jing;Liu,Qingsong[EuropeanJournalofMedicinalChemistry,2018,vol.158,p.896-916]

[2]CurrentPatentAssignee:GENFLEETTHERAPEUTICSSHANGHAI;SHANGHAIJIONGSHUOPHARMACEUTICALTECHNOLOGY-EP3613737,2020,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1010836-56-2 Molecular Formula|1010836-56-2 MDL|1010836-56-2 SMILES|1010836-56-2 4-(Hydroxymethyl)tetrahydro-2h-pyran-4-carbonitrile